+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global mRNA Synthesis Raw Material Market 2024-2028

  • PDF Icon

    Report

  • 170 Pages
  • March 2024
  • Region: Global
  • TechNavio
  • ID: 5949764
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The mRNA synthesis raw material market is forecasted to grow by USD 776.45 mn during 2023-2028, accelerating at a CAGR of 4.93% during the forecast period. The report on the mRNA synthesis raw material market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic and infectious diseases, advancements in mRNA technology, and the advantages of mRNA vaccines.

The MRNA synthesis raw material market is segmented as below:

By Application

  • Vaccine production
  • Therapeutics production
  • Others

By End-user

  • Biopharmaceutical and pharmaceutical companies
  • CROs and CMOs
  • Academic and research institutions

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the collaborations in biotechnology and manufacturing processes related to mRNA synthesis as one of the prime reasons driving the mRNA synthesis raw material market growth during the next few years. Also, growing demand for sustainable and environmentally friendly raw materials and increasing R and D investments by pharmaceutical and biopharmaceutical companies will lead to sizable demand in the market.

The report on the MRNA synthesis raw material market covers the following areas:

  • mRNA synthesis raw material market sizing
  • mRNA synthesis raw material market forecast
  • mRNA synthesis raw material market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mRNA synthesis raw material market vendors that include Bayer AG, BioNTech SE, BOCSCI Inc., CELONIC Group, Corden Pharma International GmbH, Creative Biolabs, CureVac AG, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, HONGENE, Jena Bioscience GmbH, Lonza Group Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, New England Biolabs Inc., Pfizer Inc., Promega Corp., Samsung Electronics Co. Ltd., Thermo Fisher Scientific Inc., and Yeasen Biotechnology Co. Ltd.. Also, the mRNA synthesis raw material market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global mRNA synthesis raw material market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global mrna synthesis raw material market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Vaccine production - Market size and forecast 2023-2028
Exhibit 34: Chart on Vaccine production - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Vaccine production - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Vaccine production - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Vaccine production - Year-over-year growth 2023-2028 (%)
6.4 Therapeutics production - Market size and forecast 2023-2028
Exhibit 38: Chart on Therapeutics production - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Therapeutics production - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Therapeutics production - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Therapeutics production - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ million)
Exhibit 47: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028
Exhibit 52: Chart on Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Biopharmaceutical and pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Biopharmaceutical and pharmaceutical companies - Year-over-year growth 2023-2028 (%)
7.4 CROs and CMOs - Market size and forecast 2023-2028
Exhibit 56: Chart on CROs and CMOs - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on CROs and CMOs - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on CROs and CMOs - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on CROs and CMOs - Year-over-year growth 2023-2028 (%)
7.5 Academic and research institutions - Market size and forecast 2023-2028
Exhibit 60: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 BioNTech SE
Exhibit 115: BioNTech SE - Overview
Exhibit 116: BioNTech SE - Product/Service
Exhibit 117: BioNTech SE - Key offerings
12.4 BOCSCI Inc.
Exhibit 118: BOCSCI Inc. - Overview
Exhibit 119: BOCSCI Inc. - Product/Service
Exhibit 120: BOCSCI Inc. - Key offerings
12.5 Creative Biolabs
Exhibit 121: Creative Biolabs - Overview
Exhibit 122: Creative Biolabs - Product/Service
Exhibit 123: Creative Biolabs - Key offerings
12.6 CureVac AG
Exhibit 124: CureVac AG - Overview
Exhibit 125: CureVac AG - Product/Service
Exhibit 126: CureVac AG - Key offerings
12.7 F. Hoffmann La Roche Ltd.
Exhibit 127: F. Hoffmann La Roche Ltd. - Overview
Exhibit 128: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 129: F. Hoffmann La Roche Ltd. - Key news
Exhibit 130: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 131: F. Hoffmann La Roche Ltd. - Segment focus
12.8 HONGENE
Exhibit 132: HONGENE - Overview
Exhibit 133: HONGENE - Product/Service
Exhibit 134: HONGENE - Key offerings
12.9 Jena Bioscience GmbH
Exhibit 135: Jena Bioscience GmbH - Overview
Exhibit 136: Jena Bioscience GmbH - Product/Service
Exhibit 137: Jena Bioscience GmbH - Key offerings
12.10 Lonza Group Ltd.
Exhibit 138: Lonza Group Ltd. - Overview
Exhibit 139: Lonza Group Ltd. - Business segments
Exhibit 140: Lonza Group Ltd. - Key news
Exhibit 141: Lonza Group Ltd. - Key offerings
Exhibit 142: Lonza Group Ltd. - Segment focus
12.11 Maravai LifeSciences Holdings Inc.
Exhibit 143: Maravai LifeSciences Holdings Inc. - Overview
Exhibit 144: Maravai LifeSciences Holdings Inc. - Business segments
Exhibit 145: Maravai LifeSciences Holdings Inc. - Key offerings
Exhibit 146: Maravai LifeSciences Holdings Inc. - Segment focus
12.12 Merck KGaA
Exhibit 147: Merck KGaA - Overview
Exhibit 148: Merck KGaA - Business segments
Exhibit 149: Merck KGaA - Key news
Exhibit 150: Merck KGaA - Key offerings
Exhibit 151: Merck KGaA - Segment focus
12.13 New England Biolabs Inc.
Exhibit 152: New England Biolabs Inc. - Overview
Exhibit 153: New England Biolabs Inc. - Product/Service
Exhibit 154: New England Biolabs Inc. - Key news
Exhibit 155: New England Biolabs Inc. - Key offerings
12.14 Pfizer Inc.
Exhibit 156: Pfizer Inc. - Overview
Exhibit 157: Pfizer Inc. - Product/Service
Exhibit 158: Pfizer Inc. - Key news
Exhibit 159: Pfizer Inc. - Key offerings
12.15 Promega Corp.
Exhibit 160: Promega Corp. - Overview
Exhibit 161: Promega Corp. - Product/Service
Exhibit 162: Promega Corp. - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 163: Thermo Fisher Scientific Inc. - Overview
Exhibit 164: Thermo Fisher Scientific Inc. - Business segments
Exhibit 165: Thermo Fisher Scientific Inc. - Key news
Exhibit 166: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 167: Thermo Fisher Scientific Inc. - Segment focus
12.17 Yeasen Biotechnology Co. Ltd.
Exhibit 168: Yeasen Biotechnology Co. Ltd. - Overview
Exhibit 169: Yeasen Biotechnology Co. Ltd. - Product/Service
Exhibit 170: Yeasen Biotechnology Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global mrna synthesis raw material market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Vaccine production - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Vaccine production - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Vaccine production - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Vaccine production - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Therapeutics production - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Therapeutics production - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Therapeutics production - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Therapeutics production - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Application ($ million)
Exhibits 47: Data Table on Market opportunity by Application ($ million)
Exhibits 48: Chart on End-user - Market share 2023-2028 (%)
Exhibits 49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by End-user
Exhibits 51: Data Table on Comparison by End-user
Exhibits 52: Chart on Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Biopharmaceutical and pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Biopharmaceutical and pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on CROs and CMOs - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on CROs and CMOs - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on CROs and CMOs - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on CROs and CMOs - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
Exhibits 64: Market opportunity by End-user ($ million)
Exhibits 65: Data Table on Market opportunity by End-user ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2023 and 2028
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: BioNTech SE - Overview
Exhibits 116: BioNTech SE - Product/Service
Exhibits 117: BioNTech SE - Key offerings
Exhibits 118: BOCSCI Inc. - Overview
Exhibits 119: BOCSCI Inc. - Product/Service
Exhibits 120: BOCSCI Inc. - Key offerings
Exhibits 121: Creative Biolabs - Overview
Exhibits 122: Creative Biolabs - Product/Service
Exhibits 123: Creative Biolabs - Key offerings
Exhibits 124: CureVac AG - Overview
Exhibits 125: CureVac AG - Product/Service
Exhibits 126: CureVac AG - Key offerings
Exhibits 127: F. Hoffmann La Roche Ltd. - Overview
Exhibits 128: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 129: F. Hoffmann La Roche Ltd. - Key news
Exhibits 130: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 131: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 132: HONGENE - Overview
Exhibits 133: HONGENE - Product/Service
Exhibits 134: HONGENE - Key offerings
Exhibits 135: Jena Bioscience GmbH - Overview
Exhibits 136: Jena Bioscience GmbH - Product/Service
Exhibits 137: Jena Bioscience GmbH - Key offerings
Exhibits 138: Lonza Group Ltd. - Overview
Exhibits 139: Lonza Group Ltd. - Business segments
Exhibits 140: Lonza Group Ltd. - Key news
Exhibits 141: Lonza Group Ltd. - Key offerings
Exhibits 142: Lonza Group Ltd. - Segment focus
Exhibits 143: Maravai LifeSciences Holdings Inc. - Overview
Exhibits 144: Maravai LifeSciences Holdings Inc. - Business segments
Exhibits 145: Maravai LifeSciences Holdings Inc. - Key offerings
Exhibits 146: Maravai LifeSciences Holdings Inc. - Segment focus
Exhibits 147: Merck KGaA - Overview
Exhibits 148: Merck KGaA - Business segments
Exhibits 149: Merck KGaA - Key news
Exhibits 150: Merck KGaA - Key offerings
Exhibits 151: Merck KGaA - Segment focus
Exhibits 152: New England Biolabs Inc. - Overview
Exhibits 153: New England Biolabs Inc. - Product/Service
Exhibits 154: New England Biolabs Inc. - Key news
Exhibits 155: New England Biolabs Inc. - Key offerings
Exhibits 156: Pfizer Inc. - Overview
Exhibits 157: Pfizer Inc. - Product/Service
Exhibits 158: Pfizer Inc. - Key news
Exhibits 159: Pfizer Inc. - Key offerings
Exhibits 160: Promega Corp. - Overview
Exhibits 161: Promega Corp. - Product/Service
Exhibits 162: Promega Corp. - Key offerings
Exhibits 163: Thermo Fisher Scientific Inc. - Overview
Exhibits 164: Thermo Fisher Scientific Inc. - Business segments
Exhibits 165: Thermo Fisher Scientific Inc. - Key news
Exhibits 166: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 167: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 168: Yeasen Biotechnology Co. Ltd. - Overview
Exhibits 169: Yeasen Biotechnology Co. Ltd. - Product/Service
Exhibits 170: Yeasen Biotechnology Co. Ltd. - Key offerings
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Validation techniques employed for market sizing
Exhibits 176: Information sources
Exhibits 177: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global mRNA synthesis raw material market: Bayer AG, BioNTech SE, BOCSCI Inc., CELONIC Group, Corden Pharma International GmbH, Creative Biolabs, CureVac AG, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, HONGENE, Jena Bioscience GmbH, Lonza Group Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, New England Biolabs Inc., Pfizer Inc., Promega Corp., Samsung Electronics Co. Ltd., Thermo Fisher Scientific Inc., and Yeasen Biotechnology Co. Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is collaborations in biotechnology and manufacturing processes related to mRNA synthesis.'

According to the report, one of the major drivers for this market is the growing prevalence of chronic and infectious diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • BioNTech SE
  • BOCSCI Inc.
  • CELONIC Group
  • Corden Pharma International GmbH
  • Creative Biolabs
  • CureVac AG
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • HONGENE
  • Jena Bioscience GmbH
  • Lonza Group Ltd.
  • Maravai LifeSciences Holdings Inc.
  • Merck KGaA
  • New England Biolabs Inc.
  • Pfizer Inc.
  • Promega Corp.
  • Samsung Electronics Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Yeasen Biotechnology Co. Ltd.

Related Topics

Related Reports

Global Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028 - Product Image

Global Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028

  • Report
  • 161 Pages
  • Global
From
Global Microbiomes Market 2024-2028 - Product Image

Global Microbiomes Market 2024-2028

  • Report
  • 163 Pages
  • Global
From
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024 - Product Image

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Biological Safety Testing Market Report by Product and Services, Test Type, Application, and Region 2023-2028 - Product Image

Global Biological Safety Testing Market Report by Product and Services, Test Type, Application, and Region 2023-2028

  • Report
  • 141 Pages
  • Global
From
mRNA: Therapeutics and Global Markets - Product Image

mRNA: Therapeutics and Global Markets

  • Report
  • 171 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.